Published : 24 February, 2026
The coverage includes a comprehensive pre-Budget 2026 media narrative highlighting expectations from the Union Budget with a strong focus on strengthening India’s oncology ecosystem. It features perspectives from RGCIRC through its CEO, Mr. D.S. Negi (IAS Retd.), emphasizing that while cancer drug funding remains important, effectively addressing the rising cancer burden requires parallel investment in advanced medical equipment, oncology infrastructure, preventive healthcare, and equitable access to quality treatment, particularly for underserved populations. In his remarks, he underscores that medicines alone cannot deliver optimal outcomes—sustainable cancer care demands equal prioritisation of diagnostic and treatment machinery, viewing healthcare hardware not as a luxury but as a critical public health enabler for long-term system resilience and improved patient survival.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7
DONATE